Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: February 20, 2026, 4:15 pm
Author: Getaka|Social: XLinkedIn

Gujarat Fluorochemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 20, 2026, 4:15 pm

Market Cap 37,712 Cr.
Current Price 3,430
Intrinsic Value₹2,506.19
High / Low 4,098/2,917
Stock P/E56.6
Book Value 693
Dividend Yield0.09 %
ROCE9.89 %
ROE8.29 %
Face Value 1.00
PEG Ratio-19.61

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Gujarat Fluorochemicals Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
HP Adhesives Ltd 339 Cr. 37.4 57.6/35.024.4 20.51.07 %13.6 %9.82 % 2.00
Haryana Leather Chemicals Ltd 28.4 Cr. 57.9 88.8/52.013.9 89.61.73 %8.02 %5.45 % 10.0
Hardcastle & Waud Mfg Co Ltd 46.6 Cr. 685 899/60015.7 6970.00 %6.31 %2.91 % 10.0
Grauer & Weil (India) Ltd 3,143 Cr. 69.3 111/68.222.4 22.00.72 %23.3 %17.6 % 1.00
DMCC Speciality Chemicals Ltd 618 Cr. 245 350/20823.7 93.81.02 %14.1 %9.97 % 10.0
Industry Average13,106.68 Cr767.5181.92182.870.47%12.99%25.41%6.41

All Competitor Stocks of Gujarat Fluorochemicals Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 1,4611,4181,4711,2099479921,1331,1761,1881,1481,2251,2811,210
Expenses 926895942861783786895914893854919937846
Operating Profit 536523529348164206238262295294306344364
OPM % 37%37%36%29%17%21%21%22%25%26%25%27%30%
Other Income 24211915131318991426236
Interest 23383528343734374242263033
Depreciation 57606466687281859091899091
Profit before tax 48044644926975110141149172175217247246
Tax % 26%26%26%25%29%27%28%28%30%28%12%26%27%
Net Profit 3573313322015380101108121126191184179
EPS in Rs 32.8829.9930.2118.304.827.289.199.8311.0211.4717.3916.7516.29

Last Updated: January 1, 2026, 1:16 pm

Below is a detailed analysis of the quarterly data for Gujarat Fluorochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Sales, as of Sep 2025, the value is 1,210.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,281.00 Cr. (Jun 2025) to 1,210.00 Cr., marking a decrease of 71.00 Cr..
  • For Expenses, as of Sep 2025, the value is 846.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 937.00 Cr. (Jun 2025) to 846.00 Cr., marking a decrease of 91.00 Cr..
  • For Operating Profit, as of Sep 2025, the value is 364.00 Cr.. The value appears strong and on an upward trend. It has increased from 344.00 Cr. (Jun 2025) to 364.00 Cr., marking an increase of 20.00 Cr..
  • For OPM %, as of Sep 2025, the value is 30.00%. The value appears strong and on an upward trend. It has increased from 27.00% (Jun 2025) to 30.00%, marking an increase of 3.00%.
  • For Other Income, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Jun 2025) to 6.00 Cr., marking a decrease of 17.00 Cr..
  • For Interest, as of Sep 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Jun 2025) to 33.00 Cr., marking an increase of 3.00 Cr..
  • For Depreciation, as of Sep 2025, the value is 91.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.00 Cr. (Jun 2025) to 91.00 Cr., marking an increase of 1.00 Cr..
  • For Profit before tax, as of Sep 2025, the value is 246.00 Cr.. The value appears to be declining and may need further review. It has decreased from 247.00 Cr. (Jun 2025) to 246.00 Cr., marking a decrease of 1.00 Cr..
  • For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Jun 2025) to 27.00%, marking an increase of 1.00%.
  • For Net Profit, as of Sep 2025, the value is 179.00 Cr.. The value appears to be declining and may need further review. It has decreased from 184.00 Cr. (Jun 2025) to 179.00 Cr., marking a decrease of 5.00 Cr..
  • For EPS in Rs, as of Sep 2025, the value is 16.29. The value appears to be declining and may need further review. It has decreased from 16.75 (Jun 2025) to 16.29, marking a decrease of 0.46.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 5:17 am

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3,8512,7292,6062,6503,9545,6854,2814,7374,864
Expenses 3,1051,9412,1672,0522,7853,7193,3663,6383,556
Operating Profit 7457884395981,1681,9659151,1001,308
OPM % 19%29%17%23%30%35%21%23%27%
Other Income 1127819019916117210011569
Interest 2795610511378117133147131
Depreciation 299164192202205236286355361
Profit before tax 2796453324821,0451,785595713885
Tax % 14%-93%43%146%26%26%27%23%
Net Profit 2401,246189-2227761,323435546680
EPS in Rs 17.87-19.9171.66120.9739.5949.7161.90
Dividend Payout % 15%0%0%0%6%3%8%6%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)419.17%-84.83%-217.46%449.55%70.49%-67.12%25.52%
Change in YoY Net Profit Growth (%)0.00%-504.00%-132.63%667.01%-379.06%-137.61%92.64%

Gujarat Fluorochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:13%
3 Years:6%
TTM:14%
Compounded Profit Growth
10 Years:%
5 Years:21%
3 Years:-11%
TTM:82%
Stock Price CAGR
10 Years:%
5 Years:45%
3 Years:0%
1 Year:-4%
Return on Equity
10 Years:%
5 Years:12%
3 Years:13%
Last Year:8%

Last Updated: September 5, 2025, 5:35 am

Balance Sheet

Last Updated: December 4, 2025, 1:20 am

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 111111111111111111
Reserves 4,7563,4993,7053,4824,2445,5105,9257,2427,606
Borrowings 2,0009681,7181,5811,5561,5152,0962,0801,722
Other Liabilities 2,9864416348951,0671,3351,2011,2701,279
Total Liabilities 9,7534,9196,0675,9696,8788,3719,23310,60210,618
Fixed Assets 3,8132,3052,4142,3672,5143,1114,2644,2854,263
CWIP 7242293184006801,1581,1281,5681,806
Investments 52434225988201128956
Other Assets 4,6912,0423,0763,1143,6654,1013,8404,4604,493
Total Assets 9,7534,9196,0675,9696,8788,3719,23310,60210,618

Below is a detailed analysis of the balance sheet data for Gujarat Fluorochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
  • For Reserves, as of Sep 2025, the value is 7,606.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,242.00 Cr. (Mar 2025) to 7,606.00 Cr., marking an increase of 364.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 1,722.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,080.00 Cr. (Mar 2025) to 1,722.00 Cr., marking a decrease of 358.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 1,279.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,270.00 Cr. (Mar 2025) to 1,279.00 Cr., marking an increase of 9.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 10,618.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,602.00 Cr. (Mar 2025) to 10,618.00 Cr., marking an increase of 16.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 4,263.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,285.00 Cr. (Mar 2025) to 4,263.00 Cr., marking a decrease of 22.00 Cr..
  • For CWIP, as of Sep 2025, the value is 1,806.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,568.00 Cr. (Mar 2025) to 1,806.00 Cr., marking an increase of 238.00 Cr..
  • For Investments, as of Sep 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 289.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 233.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 4,493.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,460.00 Cr. (Mar 2025) to 4,493.00 Cr., marking an increase of 33.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 10,618.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,602.00 Cr. (Mar 2025) to 10,618.00 Cr., marking an increase of 16.00 Cr..

Notably, the Reserves (7,606.00 Cr.) exceed the Borrowings (1,722.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 952782546616741739626545
Cash from Investing Activity + 589-428-1,152-373-584-476-966-1,121
Cash from Financing Activity + -1,668110622-248-144-264348599
Net Cash Flow -12746417-514-2724

Free Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow743.00-180.00438.00597.000.000.00913.00-1.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 18477799272717292
Inventory Days 736351390404314375435487
Days Payable 471127176159170174144162
Cash Conversion Cycle 449301293338216272363418
Working Capital Days 6722-0633626097
ROCE %11%9%11%20%30%10%10%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters 63.80%63.80%63.80%63.80%63.80%63.80%62.57%62.57%62.57%62.57%62.57%61.39%
FIIs 5.75%4.85%6.44%4.82%4.58%4.51%5.20%4.88%4.61%4.63%4.25%4.36%
DIIs 4.25%5.87%5.86%7.68%8.59%8.76%9.60%9.56%10.05%10.74%11.47%12.73%
Public 26.19%25.47%23.88%23.69%23.01%22.91%22.62%22.98%22.77%22.05%21.69%21.51%
No. of Shareholders 55,05461,98366,60080,61071,17867,32868,28366,59268,54466,90668,42066,493

Shareholding Pattern Chart

No. of Shareholders

Gujarat Fluorochemicals Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Mid Cap Fund 1,386,604 0.55 508.37N/AN/AN/A
Motilal Oswal Large and Midcap Fund 1,182,109 2.88 433.41,079,4522026-01-26 06:54:469.51%
Mirae Asset Large & Midcap Fund 675,177 0.57 247.54N/AN/AN/A
DSP Mid Cap Fund 607,640 1.14 222.78N/AN/AN/A
Nippon India Growth Mid Cap Fund 605,000 0.53 221.81N/AN/AN/A
Mirae Asset Focused Fund 561,639 2.65 205.91588,0382026-01-26 00:59:00-4.49%
DSP Flexi Cap Fund 536,826 1.6 196.82762,2082025-12-08 05:16:26-29.57%
DSP Large & Mid Cap Fund 479,317 1 175.73N/AN/AN/A
Axis Small Cap Fund 464,211 0.64 170.19N/AN/AN/A
Mirae Asset Large Cap Fund 447,971 0.39 164.24N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 49.7039.60120.4470.63-20.17
Diluted EPS (Rs.) 49.7039.60120.4470.63-20.17
Cash EPS (Rs.) 81.9565.64141.9389.33-1.77
Book Value[Excl.RevalReserv]/Share (Rs.) 659.93540.40502.57385.10316.70
Book Value[Incl.RevalReserv]/Share (Rs.) 659.93540.40502.57385.10316.70
Revenue From Operations / Share (Rs.) 431.07389.70517.49359.91241.28
PBDIT / Share (Rs.) 110.5292.33194.59120.9972.55
PBIT / Share (Rs.) 78.2566.29173.10102.2854.16
PBT / Share (Rs.) 64.8754.17162.4795.1543.91
Net Profit / Share (Rs.) 49.6839.60120.4470.63-20.17
NP After MI And SOA / Share (Rs.) 49.6939.60120.9771.66-19.91
PBDIT Margin (%) 25.6323.6937.6033.6130.06
PBIT Margin (%) 18.1517.0133.4528.4122.44
PBT Margin (%) 15.0413.9031.3926.4318.19
Net Profit Margin (%) 11.5210.1623.2719.62-8.35
NP After MI And SOA Margin (%) 11.5210.1623.3719.91-8.25
Return on Networth / Equity (%) 7.527.3224.0618.49-6.26
Return on Capital Employeed (%) 10.6310.8131.5222.6014.23
Return On Assets (%) 5.144.7115.8711.44-3.66
Long Term Debt / Equity (X) 0.050.060.030.100.11
Total Debt / Equity (X) 0.270.330.260.360.40
Asset Turnover Ratio (%) 0.470.480.740.590.42
Current Ratio (X) 1.701.361.501.281.08
Quick Ratio (X) 0.970.730.860.780.59
Inventory Turnover Ratio (X) 2.791.522.612.281.73
Dividend Payout Ratio (NP) (%) 6.035.053.302.790.00
Dividend Payout Ratio (CP) (%) 3.653.042.802.210.00
Earning Retention Ratio (%) 93.9794.9596.7097.210.00
Cash Earning Retention Ratio (%) 96.3596.9697.2097.790.00
Interest Coverage Ratio (X) 8.267.6218.3016.957.08
Interest Coverage Ratio (Post Tax) (X) 4.714.2712.3310.90-0.96
Enterprise Value (Cr.) 46006.8135822.2834443.0731565.587693.95
EV / Net Operating Revenue (X) 9.718.376.067.982.90
EV / EBITDA (X) 37.8835.3216.1123.759.65
MarketCap / Net Operating Revenue (X) 9.337.955.837.642.38
Retention Ratios (%) 93.9694.9496.6997.200.00
Price / BV (X) 6.095.736.007.101.81
Price / Net Operating Revenue (X) 9.337.955.837.642.38
EarningsYield 0.010.010.040.02-0.03

After reviewing the key financial ratios for Gujarat Fluorochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 49.70. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.70, marking an increase of 10.10.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 49.70. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.70, marking an increase of 10.10.
  • For Cash EPS (Rs.), as of Mar 25, the value is 81.95. This value is within the healthy range. It has increased from 65.64 (Mar 24) to 81.95, marking an increase of 16.31.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 659.93. It has increased from 540.40 (Mar 24) to 659.93, marking an increase of 119.53.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 659.93. It has increased from 540.40 (Mar 24) to 659.93, marking an increase of 119.53.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 431.07. It has increased from 389.70 (Mar 24) to 431.07, marking an increase of 41.37.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 110.52. This value is within the healthy range. It has increased from 92.33 (Mar 24) to 110.52, marking an increase of 18.19.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 78.25. This value is within the healthy range. It has increased from 66.29 (Mar 24) to 78.25, marking an increase of 11.96.
  • For PBT / Share (Rs.), as of Mar 25, the value is 64.87. This value is within the healthy range. It has increased from 54.17 (Mar 24) to 64.87, marking an increase of 10.70.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 49.68. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.68, marking an increase of 10.08.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 49.69. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.69, marking an increase of 10.09.
  • For PBDIT Margin (%), as of Mar 25, the value is 25.63. This value is within the healthy range. It has increased from 23.69 (Mar 24) to 25.63, marking an increase of 1.94.
  • For PBIT Margin (%), as of Mar 25, the value is 18.15. This value is within the healthy range. It has increased from 17.01 (Mar 24) to 18.15, marking an increase of 1.14.
  • For PBT Margin (%), as of Mar 25, the value is 15.04. This value is within the healthy range. It has increased from 13.90 (Mar 24) to 15.04, marking an increase of 1.14.
  • For Net Profit Margin (%), as of Mar 25, the value is 11.52. This value exceeds the healthy maximum of 10. It has increased from 10.16 (Mar 24) to 11.52, marking an increase of 1.36.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.52. This value is within the healthy range. It has increased from 10.16 (Mar 24) to 11.52, marking an increase of 1.36.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 7.52. This value is below the healthy minimum of 15. It has increased from 7.32 (Mar 24) to 7.52, marking an increase of 0.20.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 10.63. This value is within the healthy range. It has decreased from 10.81 (Mar 24) to 10.63, marking a decrease of 0.18.
  • For Return On Assets (%), as of Mar 25, the value is 5.14. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 5.14, marking an increase of 0.43.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.27, marking a decrease of 0.06.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 0.48 (Mar 24) to 0.47, marking a decrease of 0.01.
  • For Current Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.36 (Mar 24) to 1.70, marking an increase of 0.34.
  • For Quick Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 24) to 0.97, marking an increase of 0.24.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 4. It has increased from 1.52 (Mar 24) to 2.79, marking an increase of 1.27.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.03. This value is below the healthy minimum of 20. It has increased from 5.05 (Mar 24) to 6.03, marking an increase of 0.98.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 20. It has increased from 3.04 (Mar 24) to 3.65, marking an increase of 0.61.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 93.97. This value exceeds the healthy maximum of 70. It has decreased from 94.95 (Mar 24) to 93.97, marking a decrease of 0.98.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.35. This value exceeds the healthy maximum of 70. It has decreased from 96.96 (Mar 24) to 96.35, marking a decrease of 0.61.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 8.26. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 8.26, marking an increase of 0.64.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.71. This value is within the healthy range. It has increased from 4.27 (Mar 24) to 4.71, marking an increase of 0.44.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 46,006.81. It has increased from 35,822.28 (Mar 24) to 46,006.81, marking an increase of 10,184.53.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.71. This value exceeds the healthy maximum of 3. It has increased from 8.37 (Mar 24) to 9.71, marking an increase of 1.34.
  • For EV / EBITDA (X), as of Mar 25, the value is 37.88. This value exceeds the healthy maximum of 15. It has increased from 35.32 (Mar 24) to 37.88, marking an increase of 2.56.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 3. It has increased from 7.95 (Mar 24) to 9.33, marking an increase of 1.38.
  • For Retention Ratios (%), as of Mar 25, the value is 93.96. This value exceeds the healthy maximum of 70. It has decreased from 94.94 (Mar 24) to 93.96, marking a decrease of 0.98.
  • For Price / BV (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 3. It has increased from 5.73 (Mar 24) to 6.09, marking an increase of 0.36.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 3. It has increased from 7.95 (Mar 24) to 9.33, marking an increase of 1.38.
  • For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Gujarat Fluorochemicals Ltd as of February 20, 2026 is: ₹2,603.66

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 20, 2026, Gujarat Fluorochemicals Ltd is Overvalued by 24.09% compared to the current share price ₹3,430.00

Intrinsic Value of Gujarat Fluorochemicals Ltd as of February 20, 2026 is: ₹2,528.52

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 20, 2026, Gujarat Fluorochemicals Ltd is Overvalued by 26.28% compared to the current share price ₹3,430.00

Last 5 Year EPS CAGR: -2.89%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (5,107.67 cr) compared to borrowings (1,692.89 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (3.22 cr) and profit (437.00 cr) over the years.
  1. The stock has a low average ROCE of 12.63%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 43.38, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 331.25, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Fluorochemicals Ltd:
    1. Net Profit Margin: 11.52%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 10.63% (Industry Average ROCE: 12.99%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 7.52% (Industry Average ROE: 25.41%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 4.71
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.97
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 56.6 (Industry average Stock P/E: 81.92)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.27
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Gujarat Fluorochemicals Ltd. is a Public Limited Listed company incorporated on 06/12/2018 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24304GJ2018PLC105479 and registration number is 105479. Currently Company is involved in the business activities of Manufacture of liquefied or compressed inorganic industrial or medical gases (elemental gases, liquid or compressed air, refrigerant gases, mixed industrial gases etc.). Company's Total Operating Revenue is Rs. 4564.55 Cr. and Equity Capital is Rs. 10.99 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - OthersPlot No. 1, Khasra Nos. 264 to 267, UNA Gujarat 174303Contact not found
Management
NamePosition Held
Mr. Devendra Kumar JainChairman & Non Independent Director
Mr. Vivek Kumar JainMng.Director&Non Ind.Director
Dr. Bir KapoorDeputy Managing Director
Mr. Sunil Kumar Singh ChahuanWhole Time & Non-Independent Director
Mr. Shanti Prashad JainIndependent Director
Mr. Shailendra SwarupIndependent Director
Mr. Om Prakash LohiaIndependent Director
Mr. Chandra Prakash JainIndependent Director
Ms. Vanita BhargavaIndependent Director

FAQ

What is the intrinsic value of Gujarat Fluorochemicals Ltd?

Gujarat Fluorochemicals Ltd's intrinsic value (as of 20 February 2026) is ₹2528.52 which is 26.28% lower the current market price of ₹3,430.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹37,712 Cr. market cap, FY2025-2026 high/low of ₹4,098/2,917, reserves of ₹7,606 Cr, and liabilities of ₹10,618 Cr.

What is the Market Cap of Gujarat Fluorochemicals Ltd?

The Market Cap of Gujarat Fluorochemicals Ltd is 37,712 Cr..

What is the current Stock Price of Gujarat Fluorochemicals Ltd as on 20 February 2026?

The current stock price of Gujarat Fluorochemicals Ltd as on 20 February 2026 is ₹3,430.

What is the High / Low of Gujarat Fluorochemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Gujarat Fluorochemicals Ltd stocks is ₹4,098/2,917.

What is the Stock P/E of Gujarat Fluorochemicals Ltd?

The Stock P/E of Gujarat Fluorochemicals Ltd is 56.6.

What is the Book Value of Gujarat Fluorochemicals Ltd?

The Book Value of Gujarat Fluorochemicals Ltd is 693.

What is the Dividend Yield of Gujarat Fluorochemicals Ltd?

The Dividend Yield of Gujarat Fluorochemicals Ltd is 0.09 %.

What is the ROCE of Gujarat Fluorochemicals Ltd?

The ROCE of Gujarat Fluorochemicals Ltd is 9.89 %.

What is the ROE of Gujarat Fluorochemicals Ltd?

The ROE of Gujarat Fluorochemicals Ltd is 8.29 %.

What is the Face Value of Gujarat Fluorochemicals Ltd?

The Face Value of Gujarat Fluorochemicals Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Gujarat Fluorochemicals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports